C. Mark Mckenna
Affiliations
- Director at Apogee Therapeutics Inc. (APGE), 2025-06-21
- Director at Spyre Therapeutics Inc. (SYRE), 2025-06-02
- at Newamsterdam Pharma Co N.v. (NAMS), 2025-01-08
- at Perceptive Capital Solutions Corp (PCSC), 2024-06-11
- Director at Helix Acquisition Corp. Ii (HLXB), 2024-02-09
- Chairman, President And Ceo at Prometheus Biosciences Inc. (RXDX), 2023-06-16
- President, Salix at Bausch Health Companies Inc. (BHC), 2019-08-21
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| APGE | $49.85 | 12,500 | $623,125.00 | 20,000 | 2024-12-12 | Filing |
| APGE | $49.02 | 7,500 | $367,650.00 | 7,500 | 2024-12-12 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| RXDX | $116.14 | 25,000 | $2,903,500.00 | 55,144 | 2023-03-15 | Filing |
| RXDX | $125.13 | 10,620 | $1,328,880.60 | 55,144 | 2023-03-03 | Filing |
| RXDX | $125.26 | 700 | $87,682.00 | 55,144 | 2023-03-01 | Filing |
| RXDX | $125.10 | 13,680 | $1,711,368.00 | 55,144 | 2023-02-17 | Filing |
| RXDX | $119.87 | 25,000 | $2,996,750.00 | 55,144 | 2023-02-16 | Filing |